Article Details

Goldman Sachs set to buy 33% stake in GVK Bio at Rs 7300-crore valuation

Retrieved on: 2021-05-17 02:37:30

Tags for this article:

Click the tags to see associated articles and topics

Goldman Sachs set to buy 33% stake in GVK Bio at Rs 7300-crore valuation. View article details on hiswai:

Excerpt

Spokespersons for Goldman Sachs and ChrysCapital declined to comment. DS Brar, the chairman of GVK Biosciences, did not respond to ET's email till ...

Article found on: economictimes.indiatimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up